954 related articles for article (PubMed ID: 1700619)
1. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
[TBL] [Abstract][Full Text] [Related]
2. Expression and cell distribution of the intercellular adhesion molecule, vascular cell adhesion molecule, endothelial leukocyte adhesion molecule, and endothelial cell adhesion molecule (CD31) in reactive human lymph nodes and in Hodgkin's disease.
Ruco LP; Pomponi D; Pigott R; Gearing AJ; Baiocchini A; Baroni CD
Am J Pathol; 1992 Jun; 140(6):1337-44. PubMed ID: 1605306
[TBL] [Abstract][Full Text] [Related]
3. Cytokine (interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6)-possessing cells in lymph nodes of malignant lymphoma.
Takeshita M; Sumiyoshi Y; Masuda Y; Ohshima K; Yoshida T; Kikuchi M; Müller H
Pathol Res Pract; 1993 Feb; 189(1):18-25. PubMed ID: 8516212
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactivity for IL-1 beta and TNF alpha in human lymphoid and nonlymphoid tissues.
Ruco LP; Stoppacciaro A; Pomponi D; Boraschi D; Santoni A; Tagliabue A; Uccini S; Baroni CD
Am J Pathol; 1989 Nov; 135(5):889-97. PubMed ID: 2683798
[TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical in situ demonstration of cytokines in Hodgkin and non-Hodgkin lymphoma].
Müller H; Takeshita M; Krause J; Schuster K; Kikuchi M; Stutte HJ
Verh Dtsch Ges Pathol; 1992; 76():164-8. PubMed ID: 1283251
[TBL] [Abstract][Full Text] [Related]
6. Cell dynamics and expression of tumor necrosis factor (TNF)-alpha, interleukin-6, and TNF receptors in angioimmunoblastic lymphadenopathy-type T cell lymphoma.
Yamaguchi S; Kitagawa M; Inoue M; Tomizawa N; Kamiyama R; Hirokawa K
Exp Mol Pathol; 2000 Apr; 68(2):85-94. PubMed ID: 10716912
[TBL] [Abstract][Full Text] [Related]
7. Modulation of human endothelial cell activation by antiproliferative cytokines: exploration of arachidonic acid and intracellular cytokine pathways as possible mechanisms of action.
Delomenie C; Wautier-Pepin MP; Chappey O; Wautier JL
Exp Cell Res; 1993 Jul; 207(1):122-30. PubMed ID: 7686496
[TBL] [Abstract][Full Text] [Related]
8. Vascular activation in the histopathogenesis of Hodgkin's disease: potential role of endothelial tissue factor in intravascular thrombosis and necrosis.
Ruco LP; Pittiglio M; Dejana E; Baroni CD
J Pathol; 1993 Oct; 171(2):131-6. PubMed ID: 7506770
[TBL] [Abstract][Full Text] [Related]
9. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
[TBL] [Abstract][Full Text] [Related]
10. Anti-Leu-3a antibody reactivity with Reed-Sternberg cells of Hodgkin's disease.
Oka K; Mori N; Kojima M
Arch Pathol Lab Med; 1988 Feb; 112(2):139-42. PubMed ID: 3257383
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-8 in Hodgkin's disease. Preferential expression by reactive cells and association with neutrophil density.
Foss HD; Herbst H; Gottstein S; Demel G; Araujó I; Stein H
Am J Pathol; 1996 Apr; 148(4):1229-36. PubMed ID: 8644863
[TBL] [Abstract][Full Text] [Related]
12. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
13. Expression of enolases in T cell tumors and Hodgkin's disease.
Oka K; Mori N; Haimoto H; Kato K
Lab Invest; 1990 Dec; 63(6):792-7. PubMed ID: 2255187
[TBL] [Abstract][Full Text] [Related]
14. Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease.
Oudejans JJ; Kummer JA; Jiwa M; van der Valk P; Ossenkoppele GJ; Kluin PM; Kluin-Nelemans JC; Meijer CJ
Am J Pathol; 1996 Jan; 148(1):233-40. PubMed ID: 8546210
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic expression of Hodgkin's and Reed-Sternberg cells in Hodgkin's disease.
Hsu SM; Yang K; Jaffe ES
Am J Pathol; 1985 Feb; 118(2):209-17. PubMed ID: 3970138
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 and tumor necrosis factor-alpha in the Reed-Sternberg cells of Hodgkin's disease. Correlation with clinical and morphological "inflammatory" features.
Benharroch D; Prinsloo I; Apte RN; Yermiahu T; Geffen DB; Yanai-Inbar I; Gopas J
Eur Cytokine Netw; 1996; 7(1):51-7. PubMed ID: 8704095
[TBL] [Abstract][Full Text] [Related]
18. Real-time polymerase chain reaction determination of cytokine mRNA expression profiles in Hodgkin's lymphoma.
Malec M; Söderqvist M; Sirsjö A; MacNamara B; Lewin N; Sjöberg J; Björkholm M; Porwit-MacDonald A
Haematologica; 2004 Jun; 89(6):679-85. PubMed ID: 15194535
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of cells positive for colony-stimulating factor 1 in lymph nodes from reactive lymphadenitis, and Hodgkin's disease.
Moreau A; Praloran V; Berrada L; Coupey L; Gaillard F
Leukemia; 1992 Feb; 6(2):126-30. PubMed ID: 1552743
[TBL] [Abstract][Full Text] [Related]
20. Immunopathology of Hodgkin's disease. Characterization of Reed-Sternberg cells with monoclonal antibodies.
Strauchen JA; Dimitriu-Bona A
Am J Pathol; 1986 May; 123(2):293-300. PubMed ID: 3085509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
